Non-Invasive Biophoton Therapy for Neurocognitive and Physical Recovery in Retired Athletes with Traumatic Brain Injury: A Pilot Study in Former NFL Players

Authors

  • Tapzyanah Thomas Owner, The BELD Academy, 55 Sedona St, Sedona, AZ 86351, USA Author
  • Helen Y Gu First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA Author
  • Mariola A Smotrys First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA Author
  • Seth D Robinson First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA Author
  • James Z Liu First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA Author

DOI:

https://doi.org/10.47363/JNRRR/2025(7)230

Keywords:

Traumatic Brain Injury (TBI), Biophoton Therapy, Retired NFL Players, Neurorehabilitation, Photobiomodulation, Cognitive Function

Abstract

Objective: This pilot observational study evaluated the impact of nightly exposure to biophoton energy therapy delivered via Tesla BioHealer devices on cognitive function, physical vitality, and emotional well-being in retired NFL players experiencing chronic symptoms of traumatic brain injury (TBI).

Methods: Twelve retired NFL athletes with persistent neurocognitive, physical, and emotional impairments related to TBI used Tesla BioHealers overnight (≥8 hours/night) for an initial 60-day period, with an optional extension to 120 days. Weekly interviews and bi-weekly surveys assessed changes in sleep quality, memory, pain, energy levels, emotional stability, and interpersonal relationships. Additionally, one participant underwent a blinded, placebocontrolled EEG study with serial assessments to measure physiological changes over six weeks.

Results: By the first night, 100% of participants experienced uninterrupted sleep. By day 30, 85% reported improved cognition and reduced pain. By day 60, all participants demonstrated full mental clarity, enhanced physical and emotional functioning, and restored sexual performance. These effects persisted through the extended follow-up. Quantitative EEG from the controlled case revealed improvements in frontal alpha asymmetry, posterior peak frequency, and attentional markers, correlating with enhanced mood, cognitive readiness, and neuroregulation. One participant’s SF-36 score improved by 42% after four weeks of active treatment.

Conclusion: Biophoton therapy may offer a non-invasive, restorative approach for improving sleep, neurocognitive performance, and quality of life in individuals with chronic TBI. These preliminary results underscore the need for larger, randomized clinical trials to validate therapeutic efficacy and explore underlying mechanisms.

Author Biographies

  • Tapzyanah Thomas, Owner, The BELD Academy, 55 Sedona St, Sedona, AZ 86351, USA

    Owner, The BELD Academy, 55 Sedona St, Sedona, AZ 86351, USA 

  • Helen Y Gu, First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA

    First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA

  • Mariola A Smotrys, First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA

    First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA

  • Seth D Robinson, First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA

    First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA

  • James Z Liu, First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA

    First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE 19720, USA

Downloads

Published

2025-08-11

Issue

Vol. 7 No. 8 (2025): Volume 7 Issue 8

Section

Articles